This content is machine translated Studies in focus Interleukin-31 as a clinical target in prurigo nodularis. For the treatment of prurigo nodularis, there are rather few approved therapeutic options available today. There is a need for new effective and well-tolerated treatment options. The use of the…
View Post 6 min This content is machine translated Psoriasis as an inflammatory systemic disease Changing disease concept – implications for biologic therapy. Psoriasis is nowadays no longer understood as an exclusive skin disease, but rather as a systemic disease. Biologics specifically intervene in the disease process and have revolutionized treatment options. When…
View Post 1 min This content is machine translated Webinar Relevant aspects for the management of atopic dermatitis By way of introduction, the experts will present the principles of action of the new system therapies, the “disease burden” & comorbidities of atopic dermatitis. This will be followed by…
View Post 5 min This content is machine translated Scar treatment Laser medical applications for different types of scars – an update. The success of scar treatment depends on various factors. There is still no universally valid gold standard. An approach based on individual circumstances has proven successful. Depending on the type…
View Post 4 min This content is machine translated Atopic dermatitis Dupilumab newly approved in Switzerland from 12 years of age Especially in adolescents, moderate to severe atopic dermatitis is associated with a high degree of suffering. In the pivotal study, dupilumab resulted in rapid and sustained relief of skin lesions…
View Post 4 min This content is machine translated Psoriatic Arthritis Another JAK inhibitor has cleared the approval hurdle In patients with psoriatic arthritis who do not respond adequately to conventional DMARDs or a biologic, the EULAR recommendations advise the use of a JAK inhibitor. Recently, upadacitinib, another member…
View Post 10 min This content is machine translated Aesthetic dermatology Filler and thread lifting The natural aging process of the face leads to a loss of volume caused by the resorption of subcutaneous tissue. Over the years, not only the superficial and deep fat… CME-Test
View Post 4 min This content is machine translated Chronic wounds Modern wound care – an update In the case of wound healing disorders, an interdisciplinary diagnosis is recommended. In addition to treatment of the underlying disease, local wound treatment is the most important pillar of therapy.…
View Post 4 min This content is machine translated Benign tumors in childhood Validated tool for triage in infantile hemangiomas. Infantile hemangioma is the most common benign tumor in childhood. If therapy is initiated in time, the treatment options are very good, otherwise it can have unpleasant late consequences for…
View Post 6 min This content is machine translated Dupilumab for the treatment of atopic dermatitis Reduction of Th2-mediated inflammation – therapeutic success also in adolescents Th2-mediated inflammatory processes play a central pathogenetic role in atopic dermatitis. This is the therapeutic target of the IL4/IL13 inhibitor dupilumab, which was recently approved in Switzerland also for adolescents…
View Post 3 min This content is machine translated Baricitinib First oral JAK inhibitor approved for the treatment of atopic dermatitis The use of small molecule drugs for the treatment of atopic dermatitis has been investigated for some time. With the approval of the Janus kinase (JAK) inhibitor baricitinib, a new…
